Literature DB >> 528165

Hemodynamic effects of vasodilators across iliac stenoses in dogs.

S L Kaufman, J W Fara, E J Udoff, D P Harrington, R I White.   

Abstract

Blood flow and pressure gradients were measured in dogs across externally applied iliac artery stenoses following 3 minutes of reactive hyperemia and injection of tolazoline (0.4 mg/kg), papaverine (0.04 mg/kg), and prostaglandin E1 (0.033 micrograms/kg) into the iliac artery. Stenoses of borderline and definite hemodynamic significance at rest were produced. The gradients produced with all four modalities of vasodilatation following borderline stenosis were significantly greater than those produced with each modality before the induction of stenosis. The peak effects of all modes of vasodilatation occurred within 30 seconds, although the effects of prostaglandin E1 were continued the longest. Our results indicate that pharmacologic or reactive hyperemia can help assess the significance of borderline iliac stenoses in patients with intermittent claudication.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 528165     DOI: 10.1097/00004424-197911000-00005

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  3 in total

Review 1.  Quantification in peripheral angiography.

Authors:  D P Harrington; K Kandarpa
Journal:  Cardiovasc Intervent Radiol       Date:  1987       Impact factor: 2.740

2.  Bilateral aortoiliac pressure measurements from a single puncture site.

Authors:  J H Grollman; R Marcus; B D Averbook; F L Fiaschetti
Journal:  Cardiovasc Intervent Radiol       Date:  1990-12       Impact factor: 2.740

3.  In Vivo Validation of Patient-Specific Pressure Gradient Calculations for Iliac Artery Stenosis Severity Assessment.

Authors:  Stefan G H Heinen; Daniel A F van den Heuvel; Wouter Huberts; Sanne W de Boer; Frans N van de Vosse; Tammo Delhaas; Jean-Paul P M de Vries
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.